Article Text

other Versions

Definition and monitoring of neonatal hypoglycaemia: a nationwide survey of NHS England Neonatal Units
  1. Kathryn Charlotte Dixon1,
  2. Rebecca Louise Ferris1,
  3. Dilshad Marikar2,
  4. Mickey Chong3,
  5. Anita Mittal4,
  6. Logan Manikam5,
  7. Peter John Rose2
  1. 1School of Clinical Medicine, University of Cambridge, Cambridge, UK
  2. 2Department of Paediatrics, Peterborough City Hospital, Peterborough, Cambridgeshire, UK
  3. 3UCL Medical School, London, UK
  4. 4Department of Paediatrics, Bedford Hospital, Bedford, UK
  5. 5Population, Policy and Practice, UCL Great Ormond Street Institute of Child Health, London, UK
  1. Correspondence to Dr Dilshad Marikar, Department of Paediatrics, Peterborough City Hospital, Edith Cavell Campus, Bretton Gate, Peterborough, Cambridgeshire PE3 9GZ, UK; dilshad.marikar{at}

Statistics from

Neonatal hypoglycaemia is common; however, there is an ongoing controversy regarding its operational definition, with recent guidance from the Paediatric Endocrine Society (PES) recommending using significantly higher blood glucose thresholds and longer periods of monitoring than existing guidance.1

A 2014 survey of Australasian neonatal units identified that the most common clinical threshold for the treatment of hypoglycaemia was 2.6 mmol/L, and some units used potentially unreliable nearside blood glucose monitoring devices.2 The most recent published survey of British neonatologists showed wide variation in definitions of neonatal hypoglycaemia from <1 to <4 mmol/L.3

We surveyed neonatal units in England to assess current working practice on the definition and monitoring of neonatal hypoglycaemia.

All …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.